Price Alert

ResMed Inc. (RMD)

NYSE: RMD · Real-Time Price · USD

283.95

-0.77 (-0.27%)

At close: Aug 15, 2025, 12:14 PM

ResMed Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Revenue	1.35B	1.29B	1.28B	1.22B	1.22B	1.2B	1.16B	963.04M	1.12B	1.12B	1.03B	950.29M	914.74M	864.5M	894.87M	904.01M	876.1M	768.77M	800.01M	751.94M
Cost of Revenue	527.92M	525.33M	530.81M	507.29M	518.93M	515.4M	515.87M	362.98M	504.67M	499.15M	454.03M	409.48M	392.23M	373.3M	390.56M	397.73M	385.41M	321.51M	337.53M	313.28M
Gross Profit	820.07M	766.41M	751.27M	717.22M	704.26M	681.58M	646.93M	600.06M	617.39M	617.75M	579.72M	540.81M	522.51M	491.2M	504.32M	506.29M	490.7M	447.26M	462.48M	438.66M
Operating Income	456.57M	426.27M	417.24M	387.31M	381.22M	374.58M	275.09M	289M	275.27M	300.67M	280.19M	275.74M	255.4M	234.26M	248.71M	261.91M	241.64M	223.43M	221.72M	216.9M
Interest Income	5.76M	793K	n/a	n/a	3.63M	3.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	59K	55K	132K	117K
Pretax Income	458.05M	417.69M	418.32M	383.5M	357.73M	375.42M	259.45M	272.19M	276.8M	289.38M	273.69M	261.79M	238.09M	226.32M	237.29M	258.79M	239.21M	218M	210.59M	215.85M
Net Income	379.7M	365.04M	344.62M	311.36M	292.24M	300.49M	208.8M	219.42M	229.66M	232.5M	224.91M	210.48M	195.06M	179.01M	201.75M	203.61M	195.1M	-78.48M	179.51M	178.37M
Selling & General & Admin	265.13M	245.3M	241.61M	238.98M	242.19M	229.92M	222.16M	222.87M	240.69M	228.46M	211.67M	193.93M	194.89M	182.4M	185.36M	176.72M	181.48M	160.45M	169.47M	158.99M
Research & Development	86.44M	83.94M	81.37M	79.52M	80.86M	77.07M	73.88M	75.71M	78.14M	76.44M	69.87M	63.19M	64.32M	66.8M	62.51M	59.95M	59.88M	55.94M	54.94M	54.53M
Other Expenses	13.96M	10.89M	11.05M	11.4M	n/a	n/a	75.81M	12.48M	23.29M	12.19M	17.98M	7.95M	7.9M	7.73M	7.74M	7.71M	7.7M	7.45M	16.36M	8.24M
Operating Expenses	365.53M	340.14M	334.03M	329.91M	323.05M	306.99M	371.84M	311.06M	342.12M	317.08M	299.52M	265.07M	267.11M	256.93M	255.61M	244.38M	249.06M	223.83M	240.77M	221.76M
Interest Expense	n/a	n/a	4.79M	5.5M	9.55M	14.38M	13.8M	14.96M	14.94M	14.96M	10.34M	7.13M	5.54M	5.46M	5.95M	5.36M	5.34M	5.88M	5.92M	6.84M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	893.45M	865.47M	864.85M	837.2M	841.98M	822.4M	887.71M	674.04M	846.79M	816.23M	753.55M	674.55M	659.34M	630.24M	646.16M	642.1M	634.47M	545.34M	578.29M	535.05M
Income Tax Expense	78.35M	52.65M	73.7M	72.14M	65.5M	74.93M	50.65M	52.77M	47.14M	56.88M	48.78M	51.31M	43.03M	47.31M	35.53M	55.17M	44.11M	296.49M	31.08M	37.48M
Shares Outstanding (Basic)	146.47M	146.72M	146.86M	146.86M	146.91M	146.96M	147.13M	147.07M	147.01M	146.91M	146.7M	146.43M	146.36M	146.24M	145.99M	145.68M	145.6M	145.34M	145.25M	144.9M
Shares Outstanding (Diluted)	147.04M	147.22M	147.6M	147.6M	147.53M	147.45M	147.54M	147.49M	147.55M	147.4M	147.41M	147.13M	147M	146.96M	147.04M	146.86M	146.54M	145.51M	146.42M	146.1M
EPS (Basic)	2.59	2.49	2.35	2.12	1.99	2.04	1.42	1.49	1.56	1.58	1.53	1.44	1.33	1.22	1.38	1.40	1.34	-0.54	1.24	1.23
EPS (Diluted)	2.58	2.48	2.34	2.11	1.98	2.04	1.42	1.49	1.56	1.58	1.53	1.43	1.33	1.22	1.37	1.39	1.33	-0.54	1.23	1.22
EBITDA	532.34M	469.6M	479.01M	442.71M	422.04M	429.23M	392.69M	342.44M	341.44M	353.46M	334.14M	319.77M	300.4M	285.87M	298.32M	309.53M	287.32M	271.31M	278.46M	266.78M
EBIT	458.05M	417.69M	423.11M	389M	367.28M	374.58M	339.32M	289M	286.24M	300.67M	288.61M	275.74M	255.4M	234.26M	248.71M	261.91M	241.64M	223.43M	230.39M	216.9M
Depreciation & Amortization	74.29M	51.91M	55.9M	53.71M	54.75M	54.64M	53.37M	53.44M	55.2M	52.79M	45.54M	44.03M	45.01M	51.61M	49.61M	47.62M	45.68M	47.88M	48.07M	49.89M